Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Goodwill & Intangibles (2023 - 2025)

Zevra Therapeutics (ZVRA) has disclosed Goodwill & Intangibles for 3 consecutive years, with $6.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles fell 91.29% year-over-year to $6.4 million, compared with a TTM value of $6.4 million through Dec 2025, down 91.29%, and an annual FY2025 reading of $6.4 million, down 91.29% over the prior year.
  • Goodwill & Intangibles was $6.4 million for Q4 2025 at Zevra Therapeutics, down from $6.7 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $73.9 million in Q4 2023 and bottomed at $2.0 million in Q2 2024.
  • Average Goodwill & Intangibles over 3 years is $29.6 million, with a median of $6.6 million recorded in 2025.
  • Peak annual rise in Goodwill & Intangibles hit 236.85% in 2025, while the deepest fall reached 93.06% in 2025.
  • Year by year, Goodwill & Intangibles stood at $73.9 million in 2023, then dropped by 0.32% to $73.7 million in 2024, then plummeted by 91.29% to $6.4 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for ZVRA at $6.4 million in Q4 2025, $6.7 million in Q3 2025, and $4.7 million in Q1 2025.